PP
BSX icon

PDS Planning’s Boston Scientific BSX Stock Holding History

PDS Planning’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$520K Sell
8,289
-301
-4% -$24.1K 0.03% 262
2025
Q4 		$819K Sell
8,590
-133
-2% -$13K 0.05% 170
2025
Q3 		$852K Sell
8,723
-208
-2% -$21.5K 0.06% 153
2025
Q2 		$959K Buy
8,931
+918
+11% +$92.9K 0.07% 135
2025
Q1 		$808K Buy
8,013
+539
+7% +$54.3K 0.07% 132
2024
Q4 		$668K Buy
7,474
+113
+2% +$9.95K 0.06% 146
2024
Q3 		$617K Buy
7,361
+192
+3% +$15.1K 0.06% 157
2024
Q2 		$552K Buy
7,169
+1,690
+31% +$124K 0.06% 156
2024
Q1 		$375K Buy
5,479
+515
+10% +$33.1K 0.04% 208
2023
Q4 		$287K Buy
4,964
+496
+11% +$26.5K 0.03% 241
2023
Q3 		$236K Buy
4,468
+379
+9% +$19.9K 0.03% 258
2023
Q2 		$221K Buy
+4,089
New +$214K 0.03% 273

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PDS Planning's BSX Position: Q1 2026 in Review

PDS Planning reduced its Boston Scientific (BSX) stake by 3.5% in Q1 2026, selling an estimated $24.1K and leaving 8,289 shares worth $520K. The position accounts for 0.03% of the portfolio, ranked #262.

PDS Planning first reported a position in BSX in Q2 2023 and has held it in 12 quarters since. The position peaked at $959K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • PDS Planning held 8,289 shares of Boston Scientific worth $520K as of Q1 2026.
  • PDS Planning sold 301 Boston Scientific shares in Q1 2026, an estimated $24.1K.
  • Boston Scientific made up 0.03% of PDS Planning's portfolio in Q1 2026, its #262 holding.
  • PDS Planning first reported a position in Boston Scientific in Q2 2023 and has held it in 12 quarters since.
  • PDS Planning's Boston Scientific position peaked at $959K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on PDS Planning's 13F filing for Q1 2026, filed 22 Apr 2026.